RevMedica

With the aim to disrupt the MIS-stapling $4.3B market, RevMedica is redefining the Operating Room value stream by creating the world’s first powered and reusable surgical-devices that do not require cleaning or sterilization.   RevMedica Team: Rob Satti Thomas Wenchell

Read More

ZLife Technologies

We have developed and patented a novel preservation solution to be used as a clinical treatment for ischemia-reperfusion injury in organ transplantation, particularly intestinal transplantation. Team: Ming Zhang, MD, PhD. – President, CEO Xiang Li Andrew Hitchings

Read More

Monogram Orthopaedics

I plan to design, patent, prototype, test and manufacture custom total joint replacement implants optimized for use with a surgical robot. Monogram Orthopaedics Team: Doug Unis

Read More

Novyx Technologies

A cost-effective hydrogel dressing for chronic wounds, which enhances wound healing, reduces inflammation, risk of infection and pain, as well as provides comfort during use. Novyx Technologies Team: Waleed Abdel-Naby, PhD

Read More

BioHealthWays, Inc.

BioHealthWays prevents vision loss by delivering biologics in the eye. Our implant drastically reduces injections and improves compliance & convenience. The target market is $7B+, with 12M Americans having retinal neovascular conditions.

Read More

Lambda Vision, Inc.

LambdaVision, Inc. is commercializing a retinal implant to restore vision for the millions of patients suffering from retinitis pigmentosa (RP) and age-related macular degeneration (AMD).   LambdaVision, Inc. Team: Nicole L. Wagner, PhD, CEO Jordan A. Greco, PhD, CSO  

Read More